Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/1999
12/29/1999CN1047776C Pharmacologically active pyridine derivatives and process for the preparation thereof
12/29/1999CA2342778A1 Inhibitors of .alpha.4.beta.1 mediated cell adhesion
12/29/1999CA2336160A1 Use of compounds for treating hiv
12/29/1999CA2335513A1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release
12/29/1999CA2333750A1 Adjuvant therapy
12/29/1999CA2331923A1 Nucleic sequence and deduced protein sequence family with human endogenous retroviral motifs, and their uses
12/29/1999CA2330249A1 Artificial t helper cell epitopes as immune stimulators for synthetic peptide immunogens including immunogenic lhrh peptides
12/29/1999CA2301107A1 Pyrazolo(3,4-d)pyrimidines with anticonvulsive and antiallergic/antiasthmatic action
12/29/1999CA2294075A1 Herbal extract composition and method with immune-boosting capability
12/28/1999US6008340 Recombinant allergen, fragments thereof, corresponding recombinant DNA molecules, vectors and hosts containing the DNA molecules
12/28/1999US6008337 Polynucleotides encoding polypeptides; diagnosis and therpy for acquired immune disease syndrome, gout, addison's/crohn's diseases, adult respiratory distress syndrome, multiple sclerosis; antiarthritic/anticarcinogenic/antidiabetic agents
12/28/1999US6008336 Compacted nucleic acids and their delivery to cells
12/28/1999US6008333 Preparation of glucosaminyl muramic acid derivatives
12/28/1999US6008326 A monospecific antigen protein of haemophililus influenzae; therapy for ear infections, meningitis, pneumonia, and oral diseases
12/28/1999US6008324 A protein from a plant having a n-glucosidase chain linked by a disulfide bridge to a lectin chain; and interacts with ribosomal rna and inhibits protein sysnthesis; therapy for acquired immune deficiency syndrome; anticarcinogenic agent
12/28/1999US6008241 A photodynamic therapy
12/28/1999US6008231 Antiallergens, antihistamines, immunosuppressants, immunomodulators
12/28/1999US6008229 Treating allergy, inflammation, autoimmune disease, shock, pain
12/28/1999US6008220 A gelatinase a inhibitor for treating multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer
12/28/1999US6008192 Hydrophilic binary systems for the administration of lipophilic compounds
12/28/1999US6008030 A polynucleotide sequences encoding a protein; therapy and diagnosis of infections, respiratory and gastrointestinal disorders; toxic shock syndrome; antiarthritic and anticarcinogenic agents
12/28/1999US6007822 Immunogenic plant extract mixed into animal feed; bactericides, viricides, free radical scavengers, antioxidants
12/28/1999US6007821 Immunosuppression; organ transplants, insulin dependent diabetes
12/28/1999US6007820 Purification and characterization of MHC-peptide complexes useful in ameliorating autoimmunity
12/28/1999US6007819 Administering to mammal an antigen and a dipeptide-derivative to induce immunoglobulin g immune response; vaccines
12/28/1999US6007815 Immunology
12/28/1999CA1340866C Human c3b/c4b receptor (cr1)
12/28/1999CA1340861C Cysteine-depleted muteins of biologically active proteins
12/23/1999WO1999066065A2 Proteasomal activity
12/23/1999WO1999066051A2 Nek-related and bub1-related protein kinases
12/23/1999WO1999066037A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation
12/23/1999WO1999065942A1 Cyclic somatostatin analogs
12/23/1999WO1999065939A1 INTERACTION OF p27(KIP1) WITH FKBP-12
12/23/1999WO1999065936A2 Composition for the treatement of immune deficiencies and methods for its preparation and use
12/23/1999WO1999065933A1 Novel cyclosporins
12/23/1999WO1999065924A2 Preparation and use of superior vaccines
12/23/1999WO1999065909A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065908A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
12/23/1999WO1999065897A1 Inhibitors of glycogen synthase kinase 3
12/23/1999WO1999065884A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999WO1999065880A1 Aryl alkanoylpyridazines
12/23/1999WO1999065872A1 Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics
12/23/1999WO1999065867A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999WO1999065524A1 LZ-CD23 CHIMERA FOR INHIBITION OF IgE-MEDIATED ALLERGIC DISEASE
12/23/1999WO1999065522A1 Hla binding peptides and their uses
12/23/1999WO1999065517A2 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999WO1999065516A1 Methods and compositions for treating diseases mediated by transglutaminase activity
12/23/1999WO1999065495A1 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065466A1 Temperature-sensitive liposomal formulation
12/23/1999WO1999065449A2 INHIBITORS OF TRANSCRIPTION FACTOR NF-λB
12/23/1999WO1999065307A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/23/1999WO1999053960A3 Enhancing immune responses to genetic immunization by using a chemokine
12/23/1999WO1999051741A3 Lyst protein complexes and lyst interacting proteins
12/23/1999WO1999051213A3 The use of polyamines in the treatment of dermatological symptoms
12/23/1999WO1999049881A3 Application of hsp70 proteins
12/23/1999WO1999047168A3 Induction and enhancement of the immune response to type-2 t cell-independent antigens conjugated to lipid or lipid-containing moieties
12/23/1999WO1999045098A3 Delivery or proteins into eukaryotic cells with recombinant yersinia
12/23/1999WO1999028748A3 Hla-e binding
12/23/1999DE19827679A1 New pyrazolo(3,4-d)pyrimidine derivative adenosine A3 receptor antagonists, used for treating epilepsy, asthma or allergy
12/23/1999DE19827239A1 New polyspecific binding agents useful for treatment, prevention and diagnosis of cancer and autoimmune diseases comprises variable domains of heavy and light chains of immuoglobulins bound by a peptide
12/23/1999DE19826841A1 Arylalkanoylpyridazine Arylalkanoylpyridazine
12/23/1999CA2335452A1 Preparation and use of superior vaccines
12/23/1999CA2335294A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335293A1 Inhibitors of transcription factor nf-.kappa.b
12/23/1999CA2335184A1 Cyclic somatostatin analogs
12/23/1999CA2333554A1 Cyclic hydroxamic acids as metalloproteinase inhibitors
12/23/1999CA2333221A1 Therapeutic compositions that produce an immune response by altering the antigen
12/23/1999CA2332325A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases
12/23/1999CA2331889A1 Nek-related and bub1-related protein kinases
12/23/1999CA2331382A1 Interaction of p27(kip1) with fkbp-12
12/23/1999CA2330824A1 Hla binding peptides and their uses
12/23/1999CA2330210A1 Proteasomal activity
12/23/1999CA2301665A1 Methods and compositions for treatment of aids-associated kaposi's sarcoma
12/22/1999EP0965637A1 Fas ANTIGEN DERIVATIVES
12/22/1999EP0965345A2 Use of acemannan
12/22/1999EP0964868A1 Isolated peptides derived from mage-2
12/22/1999EP0964865A2 Pharmaceutically active tricyclic amines
12/22/1999EP0964849A1 Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
12/22/1999EP0964694A1 Mucin-mediated immunomodulation
12/22/1999EP0964691A1 Use of conantokins
12/22/1999EP0964689A1 Recombinant vaccine for diseases caused by encapsulated organisms
12/22/1999CN1239547A Pharmaceutical grade botanical drugs
12/22/1999CN1239479A Mage-1- encoding cDNA, tumor rejection antigen precursor mage-10, antibodies specific to molecule, and uses thereof
12/21/1999US6005099 For immunomodulators, antitumor agents, and components of vaccines with reduced endotoxicity
12/21/1999US6004995 Macrolide compound 0406
12/21/1999US6004974 Tricyclic 5,6-dihydro-9h-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-α]pyridines
12/21/1999US6004973 Pharmaceutical compositions comprising rafamycin coprecipitates
12/21/1999US6004968 Viricides; free of ethylenediaminetetraacetic acid and ethanol; preservative efficacy
12/21/1999US6004963 Tumor necrosis factor release inhibitors; immunomodulators
12/21/1999US6004931 Method for inhibiting growth hormone action
12/21/1999US6004815 Bacteria expressing nonsecreted cytolysin as intracellular microbial delivery vehicles to eukaryotic cells
12/21/1999US6004813 Il-6 activity inhibitor
12/21/1999US6004803 Genes encoding HSV1-TK containing a deletion of 5' cryptic promoter sites, vectors and cell lines
12/21/1999US6004792 Amino acid sequence of enzyme which controls intracellular lipids; for antiinflammatory/antiproliferative/ anticarcinogenic agents; diagnosis and prevention of autoimmune, gastrointestinal, and cardiovascular disorders
12/21/1999US6004777 Vectors having enhanced expression, and methods of making and uses thereof
12/21/1999US6004565 Administering fingolimod hydrochloride
12/21/1999US6004552 Administration of a monoclonal antibody capable of binding to a human cd40 antigen located on the surface of a human b cell, wherein the binding of the antibody to the cd40 antigen prevents the growth or differentiation of the b cell
12/21/1999CA2082951C Pulmonary administration of granulocyte colony stimulating factor
12/21/1999CA2044280C Vitamin d analogues
12/21/1999CA1340857C Synthetic plasmid transformant, feline interferon gene and method for producing feline interferon
1 ... 955 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 ... 1172